🔴 Neumora Therapeutics is trading 5% down today as growth stocks face inflation and rate concerns

Neumora Therapeutics is trading 5.13% down at $0.35 on October 14, 2026, amid pressure on broader markets and biotech shares. Supplied market context points to hotter-than-expected inflation and interest-rate concerns as a headwind for growth-oriented stocks, not a confirmed company-specific catalyst.

• No clear company-specific announcement explaining the move surfaced.
• The company’s investor-relations release listing shows its latest release dated August 14.